Physician profile
Jonathan Poe
NPI 1851646178
$2,631.54
in general payments reported to CMS, 2019-2025
10 companies · $461 in 2025
The $461 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $25.82 · 2021: $318 · 2022: $532 · 2023: $308 · 2024: $752 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090 · Entertainment: $414 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.77 |
| Entertainment | $413.85 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,142.68 | 2021-2025 | Total30, Precision 1, Dailies |
| Optos, INC. | $535.16 | 2021-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $247.85 | 2019-2024 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $217.22 | 2022-2025 | Biotrue One Day, Infuse, Miebo |
| Lkc Technologies, INC. | $140.48 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $115.51 | 2019-2021 | |
| Allergan, INC. | $105.78 | 2019-2022 | |
| Abb Con-Cise Optical Group LLC | $62.50 | 2019 | |
| Oyster Point Pharma, INC. | $33.89 | 2023 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $30.47 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Poe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.